Envelope icon

Subscribe to our newsletter

Get regular updates to your inbox.

Kesimpta (Ofatumumab)

Kesimpta (ofatumumab) is an antibody that targets the CD20 protein, found on the surface of certain types of immune cells called B-cells, that has been shown to reduce relapse rates and the risk of disability progression for people with multiple sclerosis (MS). The U.S. Food and Drug...